CPRX
Price
$23.19
Change
+$0.07 (+0.30%)
Updated
Apr 24 closing price
Capitalization
2.83B
12 days until earnings call
PLX
Price
$2.94
Change
-$0.02 (-0.68%)
Updated
Apr 24 closing price
Capitalization
229.42M
14 days until earnings call
Ad is loading...

CPRX vs PLX

Header iconCPRX vs PLX Comparison
Open Charts CPRX vs PLXBanner chart's image
Catalyst Pharmaceuticals
Price$23.19
Change+$0.07 (+0.30%)
Volume$577.26K
Capitalization2.83B
Protalix BioTherapeutics
Price$2.94
Change-$0.02 (-0.68%)
Volume$1.49M
Capitalization229.42M
CPRX vs PLX Comparison Chart
Loading...
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPRX vs. PLX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPRX is a StrongBuy and PLX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (CPRX: $23.19 vs. PLX: $2.94)
Brand notoriety: CPRX and PLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CPRX: 43% vs. PLX: 205%
Market capitalization -- CPRX: $2.83B vs. PLX: $229.42M
CPRX [@Biotechnology] is valued at $2.83B. PLX’s [@Biotechnology] market capitalization is $229.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPRX’s FA Score shows that 2 FA rating(s) are green whilePLX’s FA Score has 1 green FA rating(s).

  • CPRX’s FA Score: 2 green, 3 red.
  • PLX’s FA Score: 1 green, 4 red.
According to our system of comparison, CPRX is a better buy in the long-term than PLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPRX’s TA Score shows that 4 TA indicator(s) are bullish while PLX’s TA Score has 6 bullish TA indicator(s).

  • CPRX’s TA Score: 4 bullish, 6 bearish.
  • PLX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PLX is a better buy in the short-term than CPRX.

Price Growth

CPRX (@Biotechnology) experienced а +2.98% price change this week, while PLX (@Biotechnology) price change was +12.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

CPRX is expected to report earnings on Aug 06, 2025.

PLX is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CPRX($2.83B) has a higher market cap than PLX($229M). PLX has higher P/E ratio than CPRX: PLX (73.50) vs CPRX (17.70). PLX YTD gains are higher at: 56.383 vs. CPRX (11.116). CPRX has higher annual earnings (EBITDA): 233M vs. PLX (-6.48M). CPRX has more cash in the bank: 518M vs. PLX (27.4M). CPRX has less debt than PLX: CPRX (3.19M) vs PLX (5.68M). CPRX has higher revenues than PLX: CPRX (492M) vs PLX (45.7M).
CPRXPLXCPRX / PLX
Capitalization2.83B229M1,235%
EBITDA233M-6.48M-3,598%
Gain YTD11.11656.38320%
P/E Ratio17.7073.5024%
Revenue492M45.7M1,077%
Total Cash518M27.4M1,891%
Total Debt3.19M5.68M56%
FUNDAMENTALS RATINGS
CPRX vs PLX: Fundamental Ratings
CPRX
PLX
OUTLOOK RATING
1..100
621
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
1587
SMR RATING
1..100
3393
PRICE GROWTH RATING
1..100
4635
P/E GROWTH RATING
1..100
782
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CPRX's Valuation (66) in the Pharmaceuticals Other industry is in the same range as PLX (81) in the Servicestothe Health Industry industry. This means that CPRX’s stock grew similarly to PLX’s over the last 12 months.

CPRX's Profit vs Risk Rating (15) in the Pharmaceuticals Other industry is significantly better than the same rating for PLX (87) in the Servicestothe Health Industry industry. This means that CPRX’s stock grew significantly faster than PLX’s over the last 12 months.

CPRX's SMR Rating (33) in the Pharmaceuticals Other industry is somewhat better than the same rating for PLX (93) in the Servicestothe Health Industry industry. This means that CPRX’s stock grew somewhat faster than PLX’s over the last 12 months.

PLX's Price Growth Rating (35) in the Servicestothe Health Industry industry is in the same range as CPRX (46) in the Pharmaceuticals Other industry. This means that PLX’s stock grew similarly to CPRX’s over the last 12 months.

PLX's P/E Growth Rating (2) in the Servicestothe Health Industry industry is significantly better than the same rating for CPRX (78) in the Pharmaceuticals Other industry. This means that PLX’s stock grew significantly faster than CPRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPRXPLX
RSI
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 3 days ago
84%
Declines
ODDS (%)
Bearish Trend 18 days ago
68%
Bearish Trend 18 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
77%
Aroon
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Ad is loading...
CPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USERX16.170.29
+1.83%
US Global Investors Gld & Prec Mtls
DEMRX20.62N/A
N/A
Macquarie Emerging Markets R
NSFEX10.05N/A
N/A
Natixis Target Retirement 2025 N
BIIEX23.37N/A
N/A
Brandes International Equity I
REIGX14.82N/A
N/A
Federated Hermes International Growth R6

CPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CPRX has been loosely correlated with SANA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CPRX jumps, then SANA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPRX
1D Price
Change %
CPRX100%
+0.30%
SANA - CPRX
45%
Loosely correlated
+3.51%
VIR - CPRX
42%
Loosely correlated
+5.36%
CRNX - CPRX
41%
Loosely correlated
+3.15%
VCEL - CPRX
39%
Loosely correlated
+2.60%
FOLD - CPRX
38%
Loosely correlated
+1.41%
More

PLX and

Correlation & Price change

A.I.dvisor tells us that PLX and STOK have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PLX and STOK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
-0.68%
STOK - PLX
31%
Poorly correlated
+3.78%
ZNTL - PLX
31%
Poorly correlated
+0.67%
CPRX - PLX
31%
Poorly correlated
+0.30%
SNDX - PLX
31%
Poorly correlated
+2.31%
LXRX - PLX
31%
Poorly correlated
+4.70%
More